Therefore, it would be interesting to investigate how the GLAD‐regulated, age‐associated effector AMPs and cytokines and their mammalian counterparts affect BBB permeability in the future, which may provide us with new mechanistic insights about immune overactivation and BBB disintegration in aging and neurodegenerative diseases. The gene discussed is ADSL; the disease is neurodegenerative disease.